ArticleTechnology in cancer research & treatment

Neoadjuvant Intraperitoneal and Systemic Chemotherapy Versus Neoadjuvant Systemic Chemotherapy With Docetaxel, Oxaliplatin, and S-1 for Gastric Cancer With Peritoneal Metastasis: A Propensity Score Matched Analysis.

Xin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.